HistoSonics has raised $4.8 million in a new debt and warrants round of financing, according to a recently posted SEC filing.
HistoSonics is developing an image-guided, robotically assisted platform therapy using non-invasive and non-thermal technologies, according to the company’s website.
Money in the round came from 20 anonymous investors, with the first sale noted on April 18.
The Ann Arbor, Michigan-based company is looking for an additional $175,000 before closing the round, with a minimum investment of $50,000 required, according to the filing.
Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it all began.
DeviceTalks offers three days of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.
Early Registration is now open.